Sugi Predict

Sugi Predict / Compounds / SCHEMBL4159060

SCHEMBL4159060

SCHEMBL4159060

Cc1cc(Nc2cncc(Nc3ccc(Cl)c(CO)c3)n2)n[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.44
▸ JAK2 O60674 3/20 0.43
▸ JAK3 P52333 3/20 0.43
▸ AURKA O14965 10/20 0.42
▸ AURKB Q96GD4 7/20 0.42
▸ DHODH Q02127 1/20 0.41
▸ PAK4 O96013 3/20 0.41
▸ PLK4 O00444 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ NPC1 O15118 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GSK3B P49841 2/20 0.39
▸ RET P07949 2/20 0.37
▸ ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4170907 0.88 JAK2 (0.45) JAK2JAK3AURKAAURKBDHODH
SCHEMBL13663512 0.87 JAK2 (0.42) IDO1JAK2JAK3AURKAAURKB
SCHEMBL13663558 0.86 AURKA (0.54) JAK2JAK3AURKAAURKBDHODH
SCHEMBL4014404 0.85 JAK2 (0.46) JAK2JAK3AURKAAURKBDHODH
SCHEMBL13663498 0.84 JAK2 (0.47) JAK2JAK3AURKAAURKBDHODH
SCHEMBL4299118 0.84 DHODH (0.50) JAK2JAK3AURKAAURKBDHODH
SCHEMBL13663486 0.82 AURKA (0.57) JAK2JAK3AURKAAURKBDHODH
SCHEMBL4175167 0.81 JAK2 (0.47) JAK2JAK3AURKAAURKBDHODH
SCHEMBL4167474 0.81 JAK2 (0.43) JAK2JAK3AURKAAURKBDHODH
SCHEMBL4177096 0.81 DHODH (0.43) JAK2JAK3AURKAAURKBDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US claimed
WO-2009089042-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2009-07-16 — — WO claimed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH MAP3K1, MAP3K15, MAP3K5 IDO1 676/4885JAK2 39/4885JAK3 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.